Fortress Biotech Inc (FBIO)
1.71
+0.01
(+0.59%)
USD |
NASDAQ |
Jun 25, 16:00
1.75
+0.04
(+2.34%)
After-Hours: 20:00
Fortress Biotech Research and Development Expense (Annual): 106.07M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.07M |
| December 31, 2022 | 134.88M |
| December 31, 2021 | 128.86M |
| December 31, 2020 | 64.11M |
| December 31, 2019 | 81.33M |
| December 31, 2018 | 87.38M |
| December 31, 2017 | 52.49M |
| Date | Value |
|---|---|
| December 31, 2016 | 35.13M |
| December 31, 2015 | 29.81M |
| December 31, 2014 | 10.24M |
| December 31, 2013 | 25.68M |
| December 31, 2012 | 18.51M |
| December 31, 2011 | 29.29M |
| December 31, 2010 | 8.341M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
64.11M
Minimum
2020
134.88M
Maximum
2022
103.05M
Average
106.07M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Avenue Therapeutics Inc | 10.36M |
| Mustang Bio Inc | 41.04M |
| Journey Medical Corp | 7.541M |
| Checkpoint Therapeutics Inc | 43.57M |
| Viking Therapeutics Inc | 63.81M |